Calidi Biotherapeutics (CLDI) Other Working Capital Changes (2022 - 2025)
Calidi Biotherapeutics' quarterly Other Working Capital Changes came in at -$1.4 million in Q4 2025, down 34.92% year-on-year from -$2.2 million in Q4 2024, and down 1101.69% quarter-over-quarter from -$118000.0 in Q3 2025.
Calidi Biotherapeutics has reported Other Working Capital Changes for 4 years, with the latest figure at -$1.4 million in Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes fell 34.92% year-over-year to -$1.4 million; the trailing twelve-month figure through Dec 2025 stood at -$1.4 million (up 23.38% YoY), and the FY2025 full-year result was -$1.4 million, up 23.38% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at -$1.4 million, down from -$118000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $2.6 million in Q4 2023, with the low at -$1.6 million in Q1 2024.
- Average Other Working Capital Changes over 4 years is -$70750.0, with a median of -$96997.0 recorded in 2022.
- Year-over-year, Other Working Capital Changes surged 1672.97% in 2023 and plunged 4475.0% in 2024.
- Tracing CLDI's Other Working Capital Changes over 4 years: stood at $148000.0 in 2022, then surged by 1672.97% to $2.6 million in 2023, then plunged by 140.05% to -$1.1 million in 2024, then plunged by 34.92% to -$1.4 million in 2025.
- The last three Other Working Capital Changes figures came in at -$1.4 million (Q4 2025), -$118000.0 (Q3 2025), and -$161000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Calidi Biotherapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.42 Mn |
| Dec 31, 2025 | -1.42 Mn |
| Sep 30, 2025 | -118,000.00 |
| Sep 30, 2025 | -118,000.00 |
| Jun 30, 2025 | -161,000.00 |
| Jun 30, 2025 | -161,000.00 |
| Mar 31, 2025 | 317,000.00 |
| Mar 31, 2025 | 317,000.00 |
| Dec 31, 2024 | -1.05 Mn |
| Dec 31, 2024 | -1.05 Mn |
| Sep 30, 2024 | 832,000.00 |
| Sep 30, 2024 | 832,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Mar 31, 2024 | -1.58 Mn |
| Mar 31, 2024 | -1.58 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Sep 30, 2023 | -970,000.00 |
| Sep 30, 2023 | -970,000.00 |
| Jun 30, 2023 | 529,000.00 |
| Jun 30, 2023 | 529,000.00 |
| Mar 31, 2023 | 36,000.00 |
| Mar 31, 2023 | 36,000.00 |
| Dec 31, 2022 | 148,000.00 |
| Dec 31, 2022 | 148,000.00 |
| Sep 30, 2022 | -124,006.00 |
| Sep 30, 2022 | -124,006.00 |
| Jun 30, 2022 | -106,115.00 |
| Jun 30, 2022 | -106,115.00 |
| Mar 31, 2022 | -87,879.00 |
| Mar 31, 2022 | -87,879.00 |